Pragmatic trial baricitinib versus First biological in "Tight Control" Patients suffering from Rheumatoid Arthritis (PERFECT)
Latest Information Update: 18 Apr 2023
At a glance
- Drugs Baricitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms PERFECT
Most Recent Events
- 18 Apr 2023 Status changed from recruiting to completed.
- 20 May 2019 New trial record